The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s heparin market report forecasts the heparin market size to grow to $11.38 Billion by 2027, with a CAGR (compound annual growth rate) of more than 5%.

Learn More On The Heparin Market Report 2023 – https://www.thebusinessresearchcompany.com/report/heparin-global-market-report

Heparin Market Size Forecast
The global heparin market is expected to grow from $8.67 billion in 2022 to $9.19 billion in 2023 at a compound annual growth rate (CAGR) of 6.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The heparin market size is expected to grow to $11.38 billion in 2027 at a CAGR of 5.5%.

North America held the largest heparin market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Heparin Market Driver ­– Increase In The Prevalence Of Chronic Diseases
For instance, according to a research report published in September 2020 by the American Action Forum, the prevalence and cost of chronic diseases in the US are growing and will continue to grow because of an increase in disease prevalence among children and young adults in addition to the aging of Baby Boomer (people born between 1946 and 1964) generation. Furthermore, according to the national public health agency of the US, the Centers for Disease Control and Prevention, 6 in 10 adults in the US have a chronic disease and 4 in 10 adults have two or more chronic diseases. Therefore, the increasing prevalence of chronic diseases will drive the growth of the heparin market.

Request for A Sample Of The Global Heparin Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6684&type=smp

Key Heparin Market Trend – Product Advancement
Key players and their research wings are increasingly focusing on developing an advanced and improved heparin or heparin prefilled syringe with precision and convenience to increase their business reach and presence across the globe. For instance, in April 2021, Fresenius Kabi USA, a US-based healthcare company, launched Freeflex® IV bags. These are low-concentration sodium heparin in ready-to-use sodium chloride injection. These bags consist of 1,000 USP units of sodium heparin in a 500 mL infusion bag with 0.9% sodium chloride and 2,000 USP units of sodium heparin in a 1,000 mL infusion bag with 0.9% sodium chloride. simple, These heparin bags help reduce medication errors and guarantee patient safety.

Heparin Market Segment
1) By Product: Unfractionated Heparin, Low Molecular Weight Heparin (LMWH), Ultra-Low Molecular Weight Heparin (ULMWH)
2) By Source: Bovine, Porcine
3) By Route of Administration: Intravenous, Subcutaneous
4) By Application: Venous Thromboembolism, Atrial Fibrillation, Renal Impairment, Coronary Artery Disease, Other Applications
5) By Distribution Channel: Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies

Heparin Market Major Players and Strategies
Major players in the heparin market are Baxter, B. Braun Medical Inc., Dr. Reddy’s Laboratories Ltd., Fresenius SE & Co. KGaA, Leo Pharma A/S, Pfizer Inc., Sanofi, Opocrin S.p.A., Aspen Holdings, GlaxoSmithKline plc, Hebei Changshan Biochemical Pharmaceutical Co, Bioiberica SAU, Shenzhen Hepalink, Rovi, Sandoz, Tiandong Pharma, and Viatris Inc.

In February 2020, Opocrin Spa, an Italy-based pharmaceutical company involved in the research, production, and marketing of active pharmaceutical ingredients acquired Laboratori Derivati Organici (LDO) for an undisclosed amount. This acquisition enables Opocrin to become the world’s largest manufacturer of heparin and derivatives. LDO is an Italian firm that specializes in the extraction of active pharmaceutical components from animal organs, with an emphasis on the production of heparin and its derivatives.

The Heparin Global Market Report 2023 covers regional data on heparin market size, heparin market trends and drivers, opportunities, strategies, and heparin market competitor analysis. The countries covered in the heparin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Heparin refers to an anticoagulant type substance that slows the development of blood clots. Heparin is produced by the liver, lungs, and other human tissues, but it can also be produced in a lab. In order to prevent or dissolve blood clots, heparin may be injected into muscle or blood. Heparin is widely used in hospitals to prevent excessive coagulation during cardiac surgery, extracorporeal circulation, or dialysis.

View More Reports Related To The Heparin Market –
Anticoagulants Global Market Report 2023
Dialysis Devices And Equipment Global Market Report 2023
Hemodialysis And Peritoneal Dialysis Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: